Centre for Public Health, Queen's University Belfast, Grosvenor Road, Belfast BT12 6BJ, UK.
Department of Psychology, Faculty of Science and Technology, Bournemouth University, Fern Barrow, Talbot Campus, Bournemouth BH12 5BB, UK.
Int J Environ Res Public Health. 2018 May 31;15(6):1130. doi: 10.3390/ijerph15061130.
Adoption of a Mediterranean diet (MD) reduces cardiovascular disease (CVD) risk. However, interventions to achieve dietary behaviour change are typically resource intensive. Peer support offers a potentially low-cost approach to encourage dietary change. The primary objective of this randomised controlled trial is to explore the feasibility of peer support versus a previously tested dietetic-led intervention to encourage MD behaviour change, and to test recruitment strategies, retention and attrition in order to inform the design of a definitive trial. A total of 75 overweight adults at high CVD risk who do not follow a MD (Mediterranean Diet Score (MDS ≤ 3)) will be randomly assigned to either: a minimal intervention (written materials), a proven intervention (dietetic support, written materials and key MD foods), or a peer support intervention (group-based community programme delivered by lay peers) for 12 months. The primary end-point is change in MDS from baseline to 6 months (adoption of MD). Secondary end-points include: change in MDS from 6 to 12 months (maintenance of MD), effects on nutritional biomarkers and CVD risk factors, fidelity of implementation, acceptability and feasibility of the peer support intervention. This study will generate important data regarding the feasibility of peer support for ease of adoption of MD in an 'at risk' Northern European population. Data will be used to direct a larger scale trial, where the clinical efficacy and cost-effectiveness of peer support will be tested.
采用地中海饮食(MD)可降低心血管疾病(CVD)风险。然而,实现饮食行为改变的干预措施通常需要大量资源。同伴支持提供了一种鼓励饮食改变的潜在低成本方法。这项随机对照试验的主要目的是探索同伴支持与之前经过测试的饮食指导干预措施相比,鼓励 MD 行为改变的可行性,并测试招募策略、保留和流失情况,以为设计一项确定性试验提供信息。共有 75 名超重且 CVD 风险高的成年人未遵循 MD(地中海饮食评分(MDS ≤ 3)),他们将被随机分配到以下三组中的一组:最小干预组(书面材料)、经过验证的干预组(饮食支持、书面材料和关键 MD 食品)或同伴支持干预组(由非专业人士提供的基于小组的社区计划),为期 12 个月。主要终点是从基线到 6 个月时 MDS 的变化(采用 MD)。次要终点包括:6 至 12 个月 MDS 的变化(MD 的维持)、营养生物标志物和 CVD 风险因素的变化、实施的保真度、同伴支持干预的可接受性和可行性。这项研究将提供有关同伴支持在北欧高风险人群中易于采用 MD 的可行性的重要数据。数据将用于指导更大规模的试验,其中将测试同伴支持的临床疗效和成本效益。